Fundraising Fox
/People
Sign in

Christopher O'Donnell

Investor

Vice President, WWBD / Partner at Pfizer Venture Investments · Board director at MindImmune Therapeutics · Board director at Strata Oncology

Connecticut

Writes $100K – $15M checks · typically $10M

Find your path to Christopher

85 people in our graph can introduce you to Christopher.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Jigar Raythatha to introduce you to Christopher

You →Jigar · together at Triana Bio (2022–2026) →Christopher

Ask Jamie Chen to introduce you to Christopher

You →Jamie · 2 people · together at Enlaza Therapeutics →Christopher

Ask Sam Okafor to introduce you to Christopher

You →Sam · together at Arkuda Therapeutics →Christopher

Sign up to find every way you can get introduced to Christopher

  • Your email: the people you already email who know Christopher
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Christopher
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Christopher O'Donnell is a Partner and Vice President at Pfizer Ventures and a Board Member at Cartography Biosciences. He holds a B.S. in Chemistry from the University of Illinois and a Ph.D. in Organic Chemistry from the University of Wisconsin, Madison, with postdoctoral experience in synthetic chemistry at UC Irvine. At Pfizer, where he joined in 1999, O'Donnell has held roles as medicinal chemist, project leader, and manager, contributing to the discovery of clinical candidates in neuroscience programs and building the Antibody Drug Conjugate chemistry group in 2010, which has nominated fourteen conjugates for clinical development with seven entering clinical trials; he subsequently established the Applied Synthesis Technologies group in 2017 and is an author on over 50 publications and inventor on more than 20 patents.

Board director at MindImmune Therapeutics

Intro paths

→

In turn, Christopher can intro founders to MindImmune Therapeutics's investors below.

MindImmune Therapeutics's investors · 5

ARCH Venture PartnersChicago · $50K – $250M checks · since 2025Dolby Family VenturesSan Francisco · since 2025Pfizer Venture Investments$5M – $20M checksPfizer Venturessince 2025Slater Technology FundProvidence · since 2025

Co-founders at MindImmune Therapeutics

RB
Robert B. NelsonExecutive Officer, Director
FS
Frank S. MennitiExecutive Officer, Director
SZ
Stevin ZornExecutive Officer, Director

Board director at Strata Oncology

Intro paths

→

In turn, Christopher can intro founders to Strata Oncology's investors below.

Strata Oncology's investors · 8

Arboretum VenturesAnn Arbor · $5M – $15M checks · since 2018Baird CapitalChicago · since 2018Deerfield Management CompanyNew York · since 2018Merck Global Health Innovation FundRahway · $10M checks · since 2018MSD Global Health Innovation FundRahway · $2M – $10M checksPfizer Venture Investments$5M – $20M checksPfizer Venturessince 2018Wellington ManagementBoston · $5M – $50M checks

Co-founders at Strata Oncology

DR
Daniel RhodesExecutive Officer, Director

Experience

  1. Cartography BiosciencesBoard Membercurrent2026 — present
  2. TRexBioBoard Membercurrent2026 — present
  3. Enlaza TherapeuticsBoard Observercurrent2024 — presentLa Jolla, California
  4. Arrakis TherapeuticsMember Board Of Directorscurrent2021 — present
  5. PfizerVice President - Business Development and Partner, Pfizer Venturescurrent2022 — presentNew York, United States
  6. PfizerPartner, Pfizer Ventures & Executive Director, Emerging Sciences & Innovationcurrent2020 — present
  7. PfizerExecutive Director, External Sciences & Innovation & Principal, Pfizer Ventures2018 — 2020
  8. PfizerExecutive Director, Applied Synthesis Technology2016 — 2018Groton, CT
  9. PfizerExecutive Director, Oncology Medicinal Chemistry2015 — 2016Groton, CT
  10. PfizerSenior Director, Oncology Medicinal Chemistry2010 — 2015Groton, CT
  11. PfizerSenior Director, Neuroscience Medicinal Chemistry2009 — 2010Groton, CT
  12. PfizerDirector, Neuroscience Medicinal Chemistry2007 — 2008Groton, CT
  13. PfizerAssociate Director, Neuroscience Medicinal Chemistry2006 — 2007Groton, CT
  14. PfizerProject Team Lead, Neuroscience Medicinal Chemistry2006 — 2007Groton, CT
  15. PfizerSenior Principal Scientist, CNS Medicinal Chemistry2004 — 2006Groton, CT
  16. PfizerSenior Research Scientist, CNS Medicinal Chemistry2001 — 2004Groton, CT
  17. PfizerResearch Scientist, CNS Medicinal Chemistry1999 — 2001Groton, CT
  18. Pyxis OncologyTechnical Advisory Boardcurrent2022 — present
  19. TRIANA BiomedicinesMember Board Of Directorscurrent2022 — present
  20. MindImmune Therapeutics, Inc.Member Board of Directorscurrent2022 — presentSouth Kingston, RI
  21. Kestrel TherapeuticsBoard Observercurrent2021 — present
  22. Incendia TherapeuticsBoard of Directorscurrent2021 — present
  23. STORM Therapeutics LimitedBoard Of Directorscurrent2019 — present
  24. Strata OncologyBoard of Directorscurrent2021 — present
  25. Strata OncologyBoard observer2018 — 2021
  26. Arkuda TherapeuticsBoard Of Directors2019 — 2025
  27. Adapsyn BiosciencesBoard Of Directors2019 — 2024
  28. Pyxis OncologyMember Board Of Directors2021
  29. BioAtla LLCBoard Observer2019 — 2020
  30. Kymera TherapeuticsBoard Of Directors2019 — 2020
  31. Kymera TherapeuticsBoard Observer2018 — 2019
  32. Petra Pharma CorporationBoard Observer2019 — 2020
  33. Morphic TherapeuticBoard Observer2018 — 2019

Skills & more

Board LevelBoard GovernanceDirectorshipBoard level experienceMedicinal Chemistry45Drug Discovery46Pharmaceutical Industry20Biopharmaceuticals8Oncology13Drug Development24Drug Design19Lifesciences8
+12 moreBiotechnologyClinical DevelopmentLead ChangeADMEDMPKOrganic ChemistryHPLCChromatographyLife SciencesBiomarkersLC-MSDrug Metabolism

From Christopher's professional profile.

Colleagues at Pfizer Venture Investments

Ama Amoah
Finance Director, Business Development at Pfizer Venture Investments
Andrew J. Muratore
Vice President & Chief Counsel, M&A and Licensing at Pfizer Venture Investments
Anthony Barry
Executive Director, WWBD / Partner at Pfizer Venture Investments
Artem Smirnov
Partner at Xora
Barbara Dalton
Vice President at Pfizer Venture Investments
Boyoon Choi
Senior Corporate Counsel at Pfizer Venture Investments
Carlos Murillo
Presidente Pfizer España at Taram Capital
Denis Patrick
Investor at Pfizer Venture Investments

Network4

Scott SandellScout
Executive Chairman & Chief Investment Officer at NEA
Ben LingScout
General Partner at Bling Capital
Jerry YangScout
Founder & Co-Founder at AME Cloud Ventures
Rana Al-Hallaq
Partner at Pfizer Venture Investments

Investors connected to Christopher in public investor directories — a warm-intro map.

Frequently asked questions

Who is Christopher O'Donnell?
Christopher O'Donnell is a Partner and Vice President at Pfizer Ventures and a Board Member at Cartography Biosciences. He holds a B.S. in Chemistry from the University of Illinois and a Ph.D. in Organic Chemistry from the University of Wisconsin, Madison, with postdoctoral experience in synthetic chemistry at UC Irvine. At Pfizer, where he joined in 1999, O'Donnell has held roles as medicinal chemist, project leader, and manager, contributing to the discovery of clinical candidates in neuroscience programs and building the Antibody Drug Conjugate chemistry group in 2010, which has nominated fourteen conjugates for clinical development with seven entering clinical trials; he subsequently established the Applied Synthesis Technologies group in 2017 and is an author on over 50 publications and inventor on more than 20 patents.
Where does Christopher O'Donnell work?
Christopher O'Donnell is Vice President, WWBD / Partner at Pfizer Venture Investments and Board director at MindImmune Therapeutics and Board director at Strata Oncology.
What check size does Christopher O'Donnell write?
Christopher O'Donnell typically writes checks of $100K – $15M.
Where did Christopher O'Donnell go to school?
Christopher O'Donnell studied at UC Irvine (Post Doc, Organic Chemistry); University of Wisconsin-Madison (PhD, Organic Chemistry); University of Illinois Urbana-Champaign (Bachelor of Science - BS, Organic Chemistry).

Same school

Shared employers